Non-Erosive Reflux Disease: Clinical Trials

3 trials for Non-Erosive Reflux Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 11Unknown 1
Phase 31Completed 1

Follow Non-Erosive Reflux Disease: new trials by email Literature Review of Non-Erosive Reflux Disease trials Research Report on Non-Erosive Reflux Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease
Treatment group, Control group - Non-erosive Reflux Disease
Phase 1 / Phase 2UnknownXiyuan Hospital of China Academy of Chinese Medical Sciences2042017-01-012019-08-26
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
YH1885L(Revaprazan), Esomeprazole 20mg, placebo - Non-erosive Reflux Disease
Phase 2CompletedYuhan Corporation1492013-01-012014-07-10
Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial
Fluoxetine, Omeprazole, placebo - Non-erosive Reflux Disease
Phase 2 / Phase 3CompletedTehran University of Medical Sciences1442010-08-012012-03-06

Narrower conditions

Heartburn (1)

Broader conditions

Deglutition Disorders (3)  ·  Digestive System Diseases (3)  ·  Esophageal Diseases (3)  ·  Esophageal Motility Disorders (3)  ·  Gastroesophageal Reflux (3)  ·  Gastrointestinal Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Control Groups (1)  ·  Esomeprazole (1)  ·  Fluoxetine (1)  ·  Omeprazole (1)

Sponsors

Tehran University of Medical Sciences (1)  ·  Xiyuan Hospital of China Academy of Chinese Medical Sciences (1)  ·  Yuhan Corporation (1)

Countries

China (1)  ·  Iran (1)  ·  South Korea (1)

Top investigators

Akbar Fotouhi, MD, PhD (1)  ·  Arash Etemadi, MD, PhD (1)  ·  Behtash Saeidi, MD (1)  ·  Kaveh Hajifathalian, MD (1)  ·  Mohammad Reza Ostovaneh, MD,MPH (1)  ·  Seyed Amir Mirbagheri, MD (1)  ·  Yasin Farrokhi Khajeh Pasha, MD, MPH (1)

Results publications

PMID 24533896, PMID 34119741